
Zontivity Coupons & Discount Card - Compare Prices Near You
My prescription
Edit
2.08MG, Zontivity (30 Tablets)
Select pharmacy

CVS
$396.53
COUPON PRICE
Rite Aid
$392.58
COUPON PRICE
Walmart
$399.51
COUPON PRICE
Walgreens
$410.50
COUPON PRICEZontivity savings card
Show this card to your pharmacist
CVS
$396.53
BIN
ID
PCN
GRP
019876
LHB733A77C
CHIPPO
LHX
Powered by
Related antiplatelet drugs prescriptions
Related antiplatelet drugs prescriptions
Zontivity dosage forms
Dosage | Quantity | Price from | Per unit |
---|---|---|---|
2.08MG | 30 Tablets | $396.53 | $13.22 |
Zontivity Warnings
Vorapaxar is associated with an increased risk of bleeding, which can be severe or life-threatening, such as bleeding in the brain. It is crucial to understand the possible risks and take necessary precautions when using this medication. Below are key safety warnings and instructions:
Bleeding Risks: Vorapaxar elevates the risk of significant bleeding, including intracranial bleeding. Bleeding may be challenging to control, even if mild. Be vigilant for persistent bruises, non-stop bleeding (e.g., gum or nose bleeds), coughing or vomiting blood or material resembling coffee grounds, blood in urine, or bloody or black stools. Immediate medical attention is necessary if you experience these symptoms, especially with significant bleeding or symptoms like dizziness or fainting. Higher risk factors include older age, low body weight, kidney or liver problems, a history of bleeding issues, or concurrent use of other medications that increase bleeding risk.
Contraindications: Do not use Vorapaxar if you have a history of stroke, transient ischemic attack (TIA), or intracranial bleeding. It is also contraindicated in cases of active bleeding, such as brain hemorrhage or stomach ulcers.
Drug Interactions: Vorapaxar can interact with other medications. Drugs like clarithromycin can increase Vorapaxar levels, raising bleeding risks and side effects like anemia. Conversely, medications such as carbamazepine or phenytoin may decrease its effectiveness. Always inform your healthcare provider about all medications, including over-the-counter drugs and supplements, before starting Vorapaxar. Some medications may require dose adjustments or discontinuation. Avoid initiating new medications without consulting your healthcare provider or pharmacist.
Emergency Response: In the event of an overdose or severe bleeding, seek immediate medical assistance.
Discuss the potential benefits and risks of Vorapaxar with your doctor, especially if you have any pre-existing conditions or are taking other medications.
Zontivity Side Effects
When taking this medication, some common side effects you might experience include easy bruising or bleeding, such as nosebleeds, and anemia, which is characterized by a low blood cell count. These effects are generally mild, but if they persist or worsen, it's important to consult your healthcare provider for further guidance.
In addition to these common side effects, some individuals may experience depression or skin-related issues such as rashes or eruptions. While these are typically manageable, contacting your healthcare provider is advisable if they become severe or troublesome.
There are also rare but serious side effects associated with this medication. Immediate medical attention is necessary if you encounter symptoms of severe bleeding, which include prolonged bleeding, excessive bruising, bleeding gums, unexplained nosebleeds, blood in urine, or stools that appear bloody, black, or tarry. Vomiting blood or material that resembles coffee grounds, significant dizziness, lightheadedness, or fainting are also signs that require urgent care.
A very serious allergic reaction, though rare, may occur. If you notice symptoms like a rash, severe dizziness, swelling, particularly of the face, tongue, or throat, or difficulty breathing, seek medical help immediately. This summary does not cover all possible side effects, so if you experience any unusual symptoms, contacting your healthcare provider is recommended.
Zontivity Interactions
Certain medications can interact with this drug and alter its effectiveness. These include:
Antidepressants: Medications such as amitriptyline, clomipramine, SSRIs (like paroxetine and citalopram), and SNRIs (such as duloxetine, desvenlafaxine, and venlafaxine) may interact with this drug.
Bleeding Risk Medications: Drugs that can increase bleeding risk, including anticoagulants like dabigatran and warfarin, should be used cautiously.
Drugs Affecting Vorapaxar Removal: Some medications can alter how vorapaxar is removed from your body, affecting its function. These include azole antifungals (such as itraconazole and ketoconazole), cobicistat, HIV protease inhibitors (like nelfinavir), macrolide antibiotics (such as clarithromycin), rifamycins (like rifampin), ritonavir, St. John's wort, and seizure medications (such as carbamazepine and phenytoin).
Pain Relievers/Fever Reducers: Check labels for pain relievers and fever reducers like aspirin and NSAIDs (such as ibuprofen or naproxen), as they have anti-platelet effects that could increase side effects. However, continue low-dose aspirin (81-162 mg daily) if prescribed by your doctor to prevent heart attacks or strokes, unless advised otherwise.
Always consult with your healthcare provider or pharmacist for more information regarding drug interactions and how they might affect your treatment plan.
What is Zontivity used for?
Zontivity is used to reduce the risk of heart attack, stroke, and cardiovascular death in patients with a history of heart attack or with peripheral arterial disease. It works by inhibiting platelet aggregation, which helps prevent blood clots.
What is the mechanism of action of Zontivity?
Zontivity (vorapaxar) works by inhibiting the protease-activated receptor-1 (PAR-1) on platelets. This action prevents thrombin-induced platelet aggregation, thereby reducing the risk of thrombotic cardiovascular events.
What class of drug is vorapaxar?
Vorapaxar is classified as a protease-activated receptor-1 (PAR-1) antagonist. It is used to reduce the risk of thrombotic cardiovascular events.
Is vorapaxar FDA approved?
Yes, vorapaxar is FDA approved. It was approved by the U.S. Food and Drug Administration for use in reducing thrombotic cardiovascular events in patients with a history of myocardial infarction or peripheral arterial disease.
What is the indication of Zontivity?
Zontivity is indicated to reduce the risk of thrombotic cardiovascular events in patients with a history of myocardial infarction or with peripheral arterial disease.